Aqua Bio Technology ASA

As of June 30, 2026, Aqua Bio Technology ASA carries a market capitalization of 68.45M, placing it among publicly traded companies globally. Its enterprise value stands at 137.42M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Aqua Bio Technology ASA has 15.49M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Aqua Bio Technology ASA maintains a current ratio of 0.62, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Aqua Bio Technology ASA recorded 176,383.00 in income tax expense.

As of the close on October 22, 2026, Aqua Bio Technology ASA's stock has declined approximately 80.10% over the past 52 weeks. The 50-day moving average sits at 4.89, while the 200-day moving average is 7.59.

As of June 30, 2026, Aqua Bio Technology ASA holds 3.90M in cash and equivalents against 72.87M in total debt, resulting in a net debt position of 68.97M. Total book value stands at 41.43M, with working capital of -3.10M providing operational flexibility.

Aqua Bio Technology ASA's most recent stock split took place on February 27, 2026 with a 50:1 split ratio.